Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Anemia

Free Subscription 20.05.2024 9 Am J Hematol 6 Ann Hematol 2 Blood 1 BMC Cancer 2 BMC Pediatr 13 Br J Haematol 1 Exp Hematol 1 J Pediatr Hematol Oncol 2 N Engl J Med 2 PLoS One 3 Transfusion 1 Transplant Proc

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Hematol

1. MICHEL M, Sair M, Riviere E, Moulis G, et al
   Intravenous immunoglobulin as a rescue therapy for severe adult autoimmune hemolytic anemia: Results from a French multicenter observational study.
   Am J Hematol. 2024 May 14. doi: 10.1002/ajh.27361.
   PubMed        
   
   
2. TUBMAN VN, Maysonet D, Estrada N, Halder T, et al
   Unswitched memory B cell deficiency in children with sickle cell disease and response to pneumococcal polysaccharide vaccine.
   Am J Hematol. 2024;99:1084-1094.
   PubMed         Abstract available
   
   
3. RONDELLI D
   Non-myeloablative allogeneic HSCT in adult patients with sickle cell disease: Multiple take-home points from the Saudi Arabia experience.
   Am J Hematol. 2024;99:1021-1022.
   PubMed        
   
   
4. MINNITI CP
   Let's get "real" in sickle cell disease: Real-world data and long-term patients' registries.
   Am J Hematol. 2024;99:1019-1020.
   PubMed        
   
   
5. DOVERN E, Aydin M, DeBaun MR, Alizade K, et al
   Effect of allogeneic hematopoietic stem cell transplantation on sickle cell disease-related organ complications: A systematic review and meta-analysis.
   Am J Hematol. 2024;99:1129-1141.
   PubMed         Abstract available
   
   
6. DAMLAJ M, Alahmari B, Alaskar A, Alhejazi A, et al
   Favorable outcome of non-myeloablative allogeneic transplantation in adult patients with severe sickle cell disease: A single center experience of 200 patients.
   Am J Hematol. 2024;99:1023-1030.
   PubMed         Abstract available
   
   
7. KWIATKOWSKI JL, Thompson AA, Tricta F, Temin NT, et al
   Real-world evidence: Long-term safety of deferiprone in a large cohort of patients with sickle cell disease enrolled in a registry for up to 10 years.
   Am J Hematol. 2024;99:1031-1039.
   PubMed         Abstract available
   
   
8. JACOBS JW, Stephens LD, Chooljian DM, Sharma D, et al
   Crizanlizumab and sickle cell disease: When should medications have their approval status revoked?
   Am J Hematol. 2024;99:1016-1018.
   PubMed        
   
   
9. DE LIGT LA, Gaartman AE, Biemond BJ, Fijnvandraat K, et al
   Neutrophils in sickle cell disease: Exploring their potential role as a therapeutic target.
   Am J Hematol. 2024;99:1119-1128.
   PubMed         Abstract available
   
   

   
   Ann Hematol

10. YANG L, Niu H, Zhang T, Cao Q, et al
    A nomogram model for predicting the efficacy of cyclosporine in patients with pure red cell aplasia.
    Ann Hematol. 2024;103:1877-1885.
    PubMed         Abstract available
    
    
11. MELONI A, Pistoia L, Ricchi P, Bagnato S, et al
    Impact of genotype on multi-organ iron and complications in patients with non-transfusion-dependent beta-thalassemia intermedia.
    Ann Hematol. 2024;103:1887-1896.
    PubMed         Abstract available
    
    
12. ZHANG Z, Hu Q, Yang C, Chen M, et al
    Comparison of human leukocyte antigen in patients with paroxysmal nocturnal hemoglobinuria of different clone sizes.
    Ann Hematol. 2024;103:1897-1907.
    PubMed         Abstract available
    
    
13. KANTER J, Ataga KI, Bhasin N, Guarino S, et al
    Expert consensus on the management of infusion-related reactions (IRRs) in patients with sickle cell disease (SCD) receiving crizanlizumab: a RAND/UCLA modified Delphi panel.
    Ann Hematol. 2024;103:1909-1917.
    PubMed         Abstract available
    
    
14. NAKAMURA Y, Zaimoku Y, Yamaguchi H, Yamazaki H, et al
    Significance of absolute neutrophil count before allogeneic hematopoietic stem cell transplantation in adult patients with aplastic anemia.
    Ann Hematol. 2024 May 16. doi: 10.1007/s00277-024-05800.
    PubMed         Abstract available
    
    
15. ALAYOUBI AM, Khawaji ZY, Mohammed MA, Mercier FE, et al
    CRISPR-Cas9 system: a novel and promising era of genotherapy for beta-hemoglobinopathies, hematological malignancy, and hemophilia.
    Ann Hematol. 2024;103:1805-1817.
    PubMed         Abstract available
    
    

    
    Blood

16. SADLER KE, Price TJ
    A humanized focus on sickle cell pain.
    Blood. 2024;143:2016-2017.
    PubMed        
    
    
17. ALLISON RL, Welby E, Ehlers V, Burand A, et al
    Sickle cell disease iPSC-derived sensory neurons exhibit increased excitability and sensitization to patient plasma.
    Blood. 2024;143:2037-2052.
    PubMed         Abstract available
    
    

    
    BMC Cancer

18. CHE B, Yuan S, Zhang H, Zhai J, et al
    Causal inference between pernicious anemia and cancers: a bidirectional two-sample mendelian randomization analysis.
    BMC Cancer. 2024;24:586.
    PubMed         Abstract available
    
    

    
    BMC Pediatr

19. MANO RM, Kuona P, Misihairabgwi JM
    Determination of birth prevalence of sickle cell disease using point of care test HemotypeSC at Rundu Hospital, Namibia.
    BMC Pediatr. 2024;24:323.
    PubMed         Abstract available
    
    
20. ZHOU C, Du Y, Zhang H, Wei X, et al
    Third-generation sequencing identified a novel complex variant in a patient with rare alpha-thalassemia.
    BMC Pediatr. 2024;24:330.
    PubMed         Abstract available
    
    

    
    Br J Haematol

21. NEYER PJ, Kabore B, Nakas CT, Diallo S, et al
    Increased erythroferrone levels in malarial anaemia.
    Br J Haematol. 2024;204:2066-2070.
    PubMed         Abstract available
    
    
22. MAEDA T, Matsuda A, Kanda J, Kawabata H, et al
    Clinical impact and characteristics of erythroid dysplasia in adult aplastic anaemia: Results from a multicentre registry.
    Br J Haematol. 2024;204:2086-2096.
    PubMed         Abstract available
    
    
23. GIORGETTI A, Nyilima S, Stoffel NU, Moretti D, et al
    Stable iron ((58)Fe) isotopic measurements in Kenyan toddlers during 3 months of iron supplementation demonstrate that half of the iron absorbed is lost.
    Br J Haematol. 2024;204:2057-2065.
    PubMed         Abstract available
    
    
24. UKONMAANAHO EM, Dell'Anna S, Hakonen A, Wartiovaara-Kautto U, et al
    Biallelic hexokinase 1 (HK1) variants causative of non-spherocytic haemolytic anaemia: A case series with emphasis on the HK1 promoter variant and literature review.
    Br J Haematol. 2024;204:2040-2048.
    PubMed         Abstract available
    
    
25. BIANCHI C, Margot H, Fernandes H, Pasquet M, et al
    Autoimmune cytopenia and Kabuki syndrome in paediatrics: Insights in 11 patients.
    Br J Haematol. 2024;204:1899-1907.
    PubMed         Abstract available
    
    
26. DUNCAN BB, Lotter JL, Superata J, Barranta ME, et al
    Treatment of refractory/relapsed Diamond-Blackfan anaemia with eltrombopag.
    Br J Haematol. 2024;204:2077-2085.
    PubMed         Abstract available
    
    
27. ROGER G, Denormandie P, Gobe T, Azzolina D, et al
    Left ventricular global longitudinal strain and acute myocardial injury in patients with sickle cell disease admitted to the intensive care unit for vaso-occlusive crisis.
    Br J Haematol. 2024;204:2007-2015.
    PubMed         Abstract available
    
    
28. TOMBUL Z, Bahaj W, Ozturk M, Patel B, et al
    Ahemolytic PNH (white cell PNH): Clinical features and implications of a distinct phenotype of paroxysmal nocturnal haemoglobinuria.
    Br J Haematol. 2024;204:2121-2124.
    PubMed        
    
    
29. LIPTON JM
    Understanding complex disease-related mechanisms: Rational therapies for Diamond-Blackfan anaemia.
    Br J Haematol. 2024;204:1598-1599.
    PubMed         Abstract available
    
    
30. MANARA R, Brotto D, Barillari MR, Costa G, et al
    Hearing loss in beta-thalassaemia: An Italian multicentre case-control study.
    Br J Haematol. 2024;204:2016-2024.
    PubMed         Abstract available
    
    
31. HAGRY J, Monnet X, Mekontso-Dessap A, Chantalat C, et al
    Comprehensive assessment, pain and ventilatory management during acute complications of adult sickle cell disease: A clinical practice survey in French intensive care units.
    Br J Haematol. 2024;204:e37-e40.
    PubMed        
    
    
32. CASABIANCA M, Gauthier A, Nader E, Cannas G, et al
    Red blood cell senescence and vascular function in patients with hereditary spherocytosis with and without splenectomy.
    Br J Haematol. 2024;204:e41-e44.
    PubMed        
    
    
33. PHONGPAO K, Pholngam N, Chokchaichamnankit D, Nuamsee K, et al
    Proteomic profiling of circulating beta-thalassaemia/haemoglobin E extra-cellular vesicles reveals that association with immunoglobulin induces membrane vesiculation.
    Br J Haematol. 2024;204:2025-2039.
    PubMed         Abstract available
    
    

    
    Exp Hematol

34. ISKANDER D, Karadimitris A, Roberts I
    Harnessing single-cell technologies in the search for new therapies for Diamond-Blackfan anemia.
    Exp Hematol. 2024 May 11:104235. doi: 10.1016/j.exphem.2024.104235.
    PubMed         Abstract available
    
    

    
    J Pediatr Hematol Oncol

35. YURAN N, Ben-Ami T, Kori M
    Severe Unexplained Iron Deficiency Anemia in Children: High Yield of Upper Gastrointestinal Endoscopy Regardless of Gastrointestinal Symptoms.
    J Pediatr Hematol Oncol. 2024 May 13. doi: 10.1097/MPH.0000000000002863.
    PubMed         Abstract available
    
    

    
    N Engl J Med

36. DALEY GQ
    Welcoming the Era of Gene Editing in Medicine.
    N Engl J Med. 2024;390:1642-1645.
    PubMed        
    
    
37. MCCUNE JM, Kiem HP
    Extending Gene Medicines to All in Need.
    N Engl J Med. 2024;390:1721-1722.
    PubMed        
    
    

    
    PLoS One

38. IBRAHEEM RM, Abdulkadir MB, Aliu R, Issa A, et al
    Burden and outcome of respiratory morbidities among children and adolescents with sickle cell disease-A retrospective review of emergency presentations in some Nigerian tertiary institutions.
    PLoS One. 2024;19:e0303323.
    PubMed         Abstract available
    
    
39. ZHAO L, Vidwans A, Bearnot CJ, Rayner J, et al
    Prediction of anemia in real-time using a smartphone camera processing conjunctival images.
    PLoS One. 2024;19:e0302883.
    PubMed         Abstract available
    
    

    
    Transfusion

40. RAMSEY G, Barriteau CM
    Estimating the serological underrecognition of patients with weak or partial RHD variants.
    Transfusion. 2024;64:920-928.
    PubMed         Abstract available
    
    
41. WERNEIWSKI K, Gehrie EA
    Development of an interactive mapping tool to estimate where resources for people living with sickle cell disease may be needed most.
    Transfusion. 2024;64:772-774.
    PubMed        
    
    
42. YEE MEM, Zerra PE, McCoy JW, Covington ML, et al
    Post-transfusion biotin-labeled red blood cell survival studies in pediatric sickle cell disease with antibodies of uncertain significance.
    Transfusion. 2024;64:800-807.
    PubMed         Abstract available
    
    

    
    Transplant Proc

43. JASAK K, Jabiry-Zieniewicz Z, Stelmach D, Knap-Wielgus W, et al
    Pregnancy After Hematopoietic Cell Transplant in Severe Aplastic Anemia: Report of 2 Cases.
    Transplant Proc. 2024 May 9:S0041-1345(24)00238.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Anemia is free of charge.